Dimethyl-Fumarate

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1810 publications

Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study.

Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 31, 2026

Correction: Attenuation of experimental bronchopulmonary dysplasia by dimethyl fumarate.

Correction: Attenuation of experimental bronchopulmonary dysplasia by dimethyl fumarate.

Journal: Pediatric research

Published: May 26, 2026

Experimental Therapies in Multiple Sclerosis: Epstein-Barr Virus and Potential EBV-Related Therapeutic Strategies-A Systematic Review.

Experimental Therapies in Multiple Sclerosis: Epstein-Barr Virus and Potential EBV-Related Therapeutic Strategies-A Systematic Review.

Journal: Journal of clinical medicine

Published: May 03, 2026

Pain in the NEK: Dimethyl fumarate inactivates the NRLP3 inflammasome by covalent inhibition of NEK7.

Pain in the NEK: Dimethyl fumarate inactivates the NRLP3 inflammasome by covalent inhibition of NEK7.

Journal: Cell chemical biology

Published: April 23, 2026

Vitamin D3 and Dimethyl Fumarate Partially Restore Neurotrophic Signaling Without Altering Mitochondrial Integrity in the STZ-Induced Model of Sporadic AD.

Vitamin D3 and Dimethyl Fumarate Partially Restore Neurotrophic Signaling Without Altering Mitochondrial Integrity in the STZ-Induced Model of Sporadic AD.

Journal: International journal of molecular sciences

Published: April 21, 2026

Relapsing-remitting multiple sclerosis in a patient with Huntington's disease.

Relapsing-remitting multiple sclerosis in a patient with Huntington's disease.

Journal: BMJ case reports

Published: April 17, 2026

Microglial Nrf2 Activation Orchestrates Ferroptosis Inhibition and α-Synuclein Clearance in Parkinson's Disease.

Microglial Nrf2 Activation Orchestrates Ferroptosis Inhibition and α-Synuclein Clearance in Parkinson's Disease.

Journal: International journal of molecular sciences

Published: April 09, 2026

Industry Payments and Prescribing of Brand-Name Multiple Sclerosis Medications in Medicare.

Industry Payments and Prescribing of Brand-Name Multiple Sclerosis Medications in Medicare.

Journal: Neurology

Published: April 06, 2026

NRF2 coordinates ferroptosis and disulfidptosis in dermal papilla cells via redox metabolic reprogramming in androgenetic alopecia.

NRF2 coordinates ferroptosis and disulfidptosis in dermal papilla cells via redox metabolic reprogramming in androgenetic alopecia.

Journal: Free radical biology & medicine

Published: April 03, 2026

The Emerging Role of Dimethyl Fumarate in Alzheimer's Disease-A Systematic Review of Available Preclinical Studies.

The Emerging Role of Dimethyl Fumarate in Alzheimer's Disease-A Systematic Review of Available Preclinical Studies.

Journal: International journal of molecular sciences

Published: March 27, 2026

Reviewer Comment on Zubkow et al. "Disease Activity Following Cessation of Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis".

Reviewer Comment on Zubkow et al. "Disease Activity Following Cessation of Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis".

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: March 27, 2026

Disease Activity Following Cessation of Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis.

Disease Activity Following Cessation of Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: March 25, 2026

Showing 1-12 of 1,810

Last Updated: 06/30/2026